Conferences
ASCO GU 2024: Interaction of Age and Benefit of Treatment Intensification in Advanced Prostate Cancer: An Aggregate Meta-Analysis of 14 Randomized Trials
January 25, 2024
ASCO GU 2024: Evaluating Early Changes in Circulating Tumor DNA Tumor Fraction as a Value Add to PSA in Predicting Early Progression in mCRPC
January 25, 2024
ASCO GU 2024: Enzalutamide Combination Treatment Suspension in Men with High-Risk Biochemically Recurrent Prostate Cancer: Outcomes from EMBARK
January 25, 2024
ASCO GU 2024: Underutilization of ADT Intensification for the Treatment of Men with mHSPC: A Systematic Review of Real-World Database Studies
January 25, 2024
ASCO GU 2024: Enfortumab Vedotin as Monotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results of Stage I of a Phase 2 Trial
January 25, 2024